FDA proposes globally harmonized premarket review

The Food and Drug Administration (FDA) has proposed the implementation of a voluntary pilot premarket review program aimed at reducing the burden on manufacturers who face conflicting premarket submission format and content requirements in different countries. The proposed pilot program will evaluate the utility of an alternative procedure for device premarket submissions.

http://www.fda.gov/cdrh/ode/guidance/1347.html